AU2001284315A1 - Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof - Google Patents

Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof

Info

Publication number
AU2001284315A1
AU2001284315A1 AU2001284315A AU8431501A AU2001284315A1 AU 2001284315 A1 AU2001284315 A1 AU 2001284315A1 AU 2001284315 A AU2001284315 A AU 2001284315A AU 8431501 A AU8431501 A AU 8431501A AU 2001284315 A1 AU2001284315 A1 AU 2001284315A1
Authority
AU
Australia
Prior art keywords
modulators
oligonucleotides
therapeutic uses
receptor pathway
pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284315A
Inventor
Catherine M. Cahill
James L. Henry
Kiran Yashpal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2001284315A1 publication Critical patent/AU2001284315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
AU2001284315A 2000-08-18 2001-08-17 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof Abandoned AU2001284315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22608600P 2000-08-18 2000-08-18
US60/226,086 2000-08-18
PCT/IB2001/001510 WO2002013799A2 (en) 2000-08-18 2001-08-17 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2001284315A1 true AU2001284315A1 (en) 2002-02-25

Family

ID=22847494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284315A Abandoned AU2001284315A1 (en) 2000-08-18 2001-08-17 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof

Country Status (4)

Country Link
US (1) US20030060438A1 (en)
AU (1) AU2001284315A1 (en)
CA (1) CA2457131A1 (en)
WO (1) WO2002013799A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60314495T2 (en) * 2002-02-07 2008-03-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem AMINO ACID SEQUENCES, WHICH ARE CAPABLE OF FACILITATING THE EXPLOITATION OF A BIOLOGICAL BARRIER
US20050136103A1 (en) * 2003-09-17 2005-06-23 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
WO2005100986A1 (en) * 2004-04-15 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with tachykinin receptor 1(tacr1)
JP2009515983A (en) * 2005-11-16 2009-04-16 ザ ユニバーシティー オブ テネシー リサーチ ファウンデーション Method for the treatment of fibrotic diseases by induction of immune tolerance
KR101024860B1 (en) 2009-01-15 2011-03-31 고려대학교 산학협력단 DNA aptamer binding to Diclofenac with specificity and production method thereof
WO2012068463A2 (en) * 2010-11-18 2012-05-24 Beth Israel Deaconess Medicall Center, Inc. Methods of treating obesity by inhibiting nicotinamide n-methyl transferase (nnmt)
KR101791526B1 (en) * 2016-02-18 2017-11-01 (주)케어젠 Peptides having Hair Growth Activity and Uses Thereof
EP3737387A1 (en) 2018-01-12 2020-11-18 Bristol-Myers Squibb Company Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016547A1 (en) * 1991-03-15 1992-10-01 The Children's Medical Center Corporation Controlling nk-1 receptor-mediated responses and related diagnostics
DE69227940T2 (en) * 1991-04-25 1999-08-05 Merck & Co Inc Human neurokinin-1 receptor
AU2444692A (en) * 1991-08-07 1993-03-02 Washington University Human substance p receptor
US5750390A (en) * 1992-08-26 1998-05-12 Ribozyme Pharmaceuticals, Inc. Method and reagent for treatment of diseases caused by expression of the bcl-2 gene
US5616490A (en) * 1992-12-07 1997-04-01 Ribozyme Pharmaceuticals, Inc. Ribozymes targeted to TNF-α RNA
AU752531B2 (en) * 1997-09-17 2002-09-19 East Carolina University Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
US6013788A (en) * 1999-04-09 2000-01-11 Isis Pharmaceuticals Inc. Antisense modulation of Smad3 expression

Also Published As

Publication number Publication date
WO2002013799A2 (en) 2002-02-21
WO2002013799A3 (en) 2003-03-13
US20030060438A1 (en) 2003-03-27
CA2457131A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU3620600A (en) Skin-marking devices and their use
AU2001253479A1 (en) Targeted therapeutic agent release devices and methods of making and using the same
AU2001239079A1 (en) Combination pro/supination and flexion therapeutic mobilization device
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001234591A1 (en) Controlling activation of devices
AU2001252135A1 (en) Therapeutic agents
AU2001269508A1 (en) Drugs or cosmetics
AU8676698A (en) Devices for providing therapeutic substances
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU715620C (en) Therapeutic methods and uses
AU2002254342A1 (en) Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
AU1164601A (en) Therapeutic use and formulation
AU7757400A (en) Antiviral therapy use of p-glycoprotein modulators
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2001232948A1 (en) Controlled release of drugs
AU2001226387A1 (en) Methods of identifying modulators of the fgf receptor
AU2001284315A1 (en) Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof
AU2001243515A1 (en) Combination drug therapy
AU2002336437A1 (en) Therapeutic uses of complement receptor 2
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2001248824A1 (en) Thermotherapy device
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III